Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Treasury Shares (2020 - 2025)

Abeona Therapeutics (ABEO) has 4 years of Treasury Shares data on record, last reported at $4000.0 in Q3 2014.

  • For Q3 2014, Treasury Shares changed 0.0% year-over-year to $4000.0; the TTM value through Sep 2014 reached $4000.0, changed 0.0%, while the annual FY2013 figure was $4000.0, 0.0% changed from the prior year.
  • Treasury Shares reached $4.1 million in Q3 2025 per ABEO's latest filing, down from $4.9 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $5.3 million in Q1 2025 and bottomed at $61108.0 in Q2 2022.
  • Average Treasury Shares over 5 years is $2.3 million, with a median of $2.4 million recorded in 2023.
  • The widest YoY moves for Treasury Shares: up 0.0% in 2012, down 0.0% in 2012.
  • A 4-year view of Treasury Shares shows it stood at $4000.0 in 2011, then changed by 0.0% to $4000.0 in 2012, then changed by 0.0% to $4000.0 in 2013, then changed by 0.0% to $4000.0 in 2014.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $4000.0 in Q3 2014, $4000.0 in Q2 2014, and $4000.0 in Q1 2014.